Morgan Stanley’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Sell |
|
|||||
|
2025
Q1 | $5.74M | Sell |
|
|||||
|
2024
Q4 | $10.4M | Buy |
|
|||||
|
2024
Q3 | $18.4M | Buy |
|
|||||
|
2024
Q2 | $30.7M | Sell |
|
|||||
|
2024
Q1 | $49.4M | Sell |
|
|||||
|
2023
Q4 | $63.6M | Buy |
|
|||||
|
2023
Q3 | $18.7M | Sell |
|
|||||
|
2023
Q2 | $28.3M | Sell |
|
|||||
|
2023
Q1 | $29.9M | Buy |
|
|||||
|
2022
Q4 | $32.4M | Sell |
|
|||||
|
2022
Q3 | $16.3M | Buy |
|
|||||
|
2022
Q2 | $2.19M | Sell |
|
|||||
|
2022
Q1 | $6.35M | Sell |
|
|||||
|
2021
Q4 | $9.52M | Buy |
|
|||||
|
2021
Q3 | $9.94M | Sell |
|
|||||
|
2021
Q2 | $10.4M | Buy |
|
|||||
|
2021
Q1 | $11.8M | Buy |
|
|||||
|
2020
Q4 | $10.2M | Buy |
|